Diverse antitoxins use a shared mechanism to stop toxins

AbiE antitoxins neutralize toxins by inducing phosphorylation of specific residues.

AbiE antitoxins neutralize toxins through a shared mechanism. These antitoxins induce the phosphorylation of conserved serine or threonine residues in partner toxins. This process results in toxin inactivation.

The AbiE toxin-antitoxin (TA) system from Mycobacterium tuberculosis uses antitoxin-dependent phosphorylation. A search of the IMG/M database shows AbiE TA systems include a conserved toxin family. This family pairs with six distinct groups of antitoxins, including four newly identified groups.

Most antitoxins share a conserved winged helix-turn-helix (wHTH) domain. They also share a C-terminal structurally homologous domain (CTD). The CTD is required for toxin inactivation.

The antitoxin CTD shows homology to nucleotidyltransferases (NTases). This includes the AbiE toxin itself and the MntA antitoxins. This suggests type VII antitoxins may have evolved from an ancestral NTase superfamily.

DNA-binding capabilities are diverse among these systems. Some antitoxins function as transcriptional regulators. Others lack detectable DNA-binding activity.

Key facts

  • AbiE antitoxins induce phosphorylation of serine or threonine residues to inactivate toxins.
  • The antitoxin CTD shows homology to nucleotidyltransferases (NTases).
  • Type VII antitoxins may have evolved from an ancestral NTase superfamily.

All sections

Edition